P12931 SRC_HUMAN
Gene name: SRC
Protein name: Proto-oncogene tyrosine-protein kinase Src
List of molecules and drugs that target protein P12931
# | DrugDomain Data | DrugBank Accession | Name | Drug action | Affinity data | InChI Key | SMILES |
---|---|---|---|---|---|---|---|
1 | P12931_DB01254 | DB01254 | Dasatinib | multitarget | Ki(nM) = 0.016 IC50(nM) = 0.21 Kd(nM) = 0.21 | ZBNZXTGUTAYRHI-UHFFFAOYSA-N | CC1=NC(NC2=NC=C(S2)C(=O)NC2=C(C)C=CC=C2Cl)=CC(=N1)N1CCN(CCO)CC1 |
2 | P12931_DB01678 | DB01678 | RU84687 | n/a | SAFPHFWYRLLBFO-NSOVKSMOSA-N | CC(=O)N[C@@H](CC1=CC=C(OP(O)(O)=O)C(C=O)=C1)C(=O)N[C@H]1CCCCN(CC2=CC=C(C=C2)C2=CC=CC=C2)C1=O | |
3 | P12931_DB01866 | DB01866 | RU79256 | n/a | USNMCXDGQQVYSW-SSDOTTSWSA-N | [H][C@](C(O)=O)(C1=CC=CC=C1)S(O)(=O)=O | |
4 | P12931_DB01893 | DB01893 | N6-Benzyl Adenosine-5'-Diphosphate | n/a | MRHGMAGSDAQUFH-LSCFUAHRSA-N | [H][C@]1(COP(O)(=O)OP(O)(O)=O)O[C@@]([H])(N2C=NC3=C(NCC4=CC=CC=C4)N=CN=C23)[C@]([H])(O)[C@]1([H])O | |
5 | P12931_DB01908 | DB01908 | RU85493 | n/a | MWEWSHNGVWABKG-SVBPBHIXSA-N | CC(=O)N[C@@H](CC1=CC=C(OCC(O)=O)C(=C1)P(O)(O)=O)C(=O)N[C@H]1CCCCN(CC2=CC=C(C=C2)C2=CC=CC=C2)C1=O | |
6 | P12931_DB01947 | DB01947 | RU78262 | n/a | IC50(nM) = 80000.0 | BYNSFVCWJXZPOW-UHFFFAOYSA-N | OP(O)(=O)OC1=C(C=O)C=CC=C1 |
7 | P12931_DB01962 | DB01962 | Phosphonotyrosine | n/a | DCWXELXMIBXGTH-QMMMGPOBSA-N | N[C@@H](CC1=CC=C(OP(O)(O)=O)C=C1)C(O)=O | |
8 | P12931_DB02175 | DB02175 | Malonic acid | n/a | IC50(nM) = 4.0E7 | OFOBLEOULBTSOW-UHFFFAOYSA-N | OC(=O)CC(O)=O |
9 | P12931_DB02336 | DB02336 | RU83876 | n/a | WCMLXBUNHNAMNH-UIOOFZCWSA-N | CC(=O)N[C@@H](CC1=CC(=C(C=C1)P(O)(O)=O)P(O)(O)=O)C(=O)N[C@H]1CCCCN(CC2=CC=C(C=C2)C2=CC=CC=C2)C1=O | |
10 | P12931_DB02432 | DB02432 | RU90395 | n/a | RLLAUERCSKPFGD-VMPREFPWSA-N | COC(=O)C1=C(C=CC(C[C@H](NC(C)=O)C(=O)N[C@H]2CCCCN(CC3=CC=C(C=C3)C3=CC=CC=C3)C2=O)=C1)C(F)(C(O)=O)C(O)=O | |
11 | P12931_DB02762 | DB02762 | RU79072 | n/a | IC50(nM) = 3600000.0 | NQLPTOOPFMPCHQ-UHFFFAOYSA-N | OP(O)(=O)OC1=CC=CC2=CC=C(N=C12)C#N |
12 | P12931_DB02908 | DB02908 | RU78783 | n/a | IC50(nM) = 3900000.0 | FRLTXWJJMCIUNT-UHFFFAOYSA-N | OP(O)(=O)C(C1=CC=CC=C1)P(O)(O)=O |
13 | P12931_DB03023 | DB03023 | 1-Tert-Butyl-3-(4-Chloro-Phenyl)-1h-Pyrazolo[3,4-D]Pyrimidin-4-Ylamine | n/a | PBBRWFOVCUAONR-UHFFFAOYSA-O | CC(C)(C)N1[NH+]=C(C2=C1N=CN=C2N)C1=CC=C(Cl)C=C1 | |
14 | P12931_DB03078 | DB03078 | PASBN | n/a | PWDTUFYQEUEVQD-UHFFFAOYSA-N | O[P@@](=O)(OCC1=CC=CC=C1)OC1=C(C=O)C=CC=C1 | |
15 | P12931_DB03104 | DB03104 | 2-[4-[(Z)-2-Acetamido-3-oxo-3-[[(3S)-2-oxo-1-[(4-phenylphenyl)methyl]azepan-3-yl]amino]prop-1-enyl]-2-formylphenyl]acetic acid | n/a | NKMPOVPTYDXGEC-MNRBYUMSSA-N | CC(=O)N\C(=C/C1=CC=C(CC(O)=O)C(C=O)=C1)C(=O)N[C@H]1CCCCN(CC2=CC=C(C=C2)C2=CC=CC=C2)C1=O | |
16 | P12931_DB03114 | DB03114 | PAS219 | n/a | YBEVTZVQKMYQPM-UHFFFAOYSA-N | O[P@@](=O)(OCC1CCCCC1)OC1=C(C=O)C=CC=C1 | |
17 | P12931_DB03217 | DB03217 | DPI59 | n/a | AXIBZLYWMBUYRV-NSHDSACASA-N | [H][C@@](O)(C1=CC=CC2=CC=CC=C12)P(O)(O)=O | |
18 | P12931_DB03268 | DB03268 | RU82197 | n/a | WKTQBTSOHBKBRW-VMPREFPWSA-N | CC(=O)N[C@@H](CC1=CC(C=O)=C(C=C1)C(O)=O)C(=O)N[C@H]1CCCCN(CC2=CC=C(C=C2)C2=CC=CC=C2)C1=O | |
19 | P12931_DB03298 | DB03298 | Phenylphosphate | n/a | IC50(nM) = 300000.0 | CMPQUABWPXYYSH-UHFFFAOYSA-N | OP(O)(=O)OC1=CC=CC=C1 |
20 | P12931_DB03306 | DB03306 | RU78300 | n/a | IC50(nM) = 95000.0 | CGEZBCISRKFHLZ-UHFFFAOYSA-N | COC1=CC=CC(C=O)=C1OP(O)(O)=O |
21 | P12931_DB03525 | DB03525 | RU79073 | n/a | IC50(nM) = 300000.0 | NSJSAHCLJYVEDM-UHFFFAOYSA-N | OP(O)(=O)OC1=C2NCCCC2=CC=C1 |
22 | P12931_DB03591 | DB03591 | RU82209 | n/a | LVZDQVATAQEMCX-NSOVKSMOSA-N | CC(=O)N[C@@H](CC1=CC=C(C=C1)C(F)(F)P(O)(O)=O)C(=O)N[C@H]1CCCCN(CC2=CC=C(C=C2)C2=CC=CC=C2)C1=O | |
23 | P12931_DB03628 | DB03628 | ISO24 | n/a | IC50(nM) = 4400000.0 | KGNSYMGWPCEFDZ-UHFFFAOYSA-N | CCC1=CC=C(NC(=O)P(O)(O)=O)C=C1 |
24 | P12931_DB03712 | DB03712 | RU85053 | n/a | CEKLBQMULVLLTD-VMPREFPWSA-N | CC(=O)N[C@@H](CC1=CC(C(O)=O)=C(CC(O)=O)C=C1)C(=O)N[C@H]1CCCCN(CC2=CC=C(C=C2)C2=CC=CC=C2)C1=O | |
25 | P12931_DB03828 | DB03828 | RU78299 | n/a | IC50(nM) = 39000.0 | NAYNUXXSJZLKPW-UHFFFAOYSA-N | CC1=CC(C=O)=C(OP(O)(O)=O)C(C=O)=C1 |
26 | P12931_DB03902 | DB03902 | Oxalic Acid | n/a | MUBZPKHOEPUJKR-UHFFFAOYSA-N | OC(=O)C(O)=O | |
27 | P12931_DB04080 | DB04080 | RU78191 | n/a | IC50(nM) = 200000.0 | WWYDYZMNFQIYPT-UHFFFAOYSA-N | OC(=O)C(C(O)=O)C1=CC=CC=C1 |
28 | P12931_DB04272 | DB04272 | Citric acid | n/a | KRKNYBCHXYNGOX-UHFFFAOYSA-N | OC(=O)CC(O)(CC(O)=O)C(O)=O | |
29 | P12931_DB04495 | DB04495 | Paratoulene phosphate | n/a | GGPXNASQNUOIPB-NSOVKSMOSA-N | CC(=O)N[C@@H](CC1=CC=C(OP(O)(O)=O)C=C1)C(=O)N[C@H]1CCCCN(CC2=CC=C(C=C2)C2=CC=CC=C2)C1=O | |
30 | P12931_DB04739 | DB04739 | 4-[(4-METHYL-1-PIPERAZINYL)METHYL]-N-[3-[[4-(3-PYRIDINYL)-2-PYRIMIDINYL]AMINO]PHENYL]-BENZAMIDE | n/a | IC50(nM) = 7800.0 | JHMBUEWQJDGKGS-UHFFFAOYSA-N | CN1CCN(CC2=CC=C(C=C2)C(=O)NC2=CC=CC(NC3=NC=CC(=N3)C3=CN=CC=C3)=C2)CC1 |
31 | P12931_DB04751 | DB04751 | Purvalanol A | n/a | IC50(nM) = 240.0 | PMXCMJLOPOFPBT-HNNXBMFYSA-N | [H][C@@](CO)(NC1=NC(NC2=CC=CC(Cl)=C2)=C2N=CN(C(C)C)C2=N1)C(C)C |
32 | P12931_DB06137 | DB06137 | Tirbanibulin | inhibitor | HUNGUWOZPQBXGX-UHFFFAOYSA-N | O=C(CC1=CC=C(C=N1)C1=CC=C(OCCN2CCOCC2)C=C1)NCC1=CC=CC=C1 | |
33 | P12931_DB06616 | DB06616 | Bosutinib | inhibitor | IC50(nM) = 1.0 Kd(nM) = 1.0 | UBPYILGKFZZVDX-UHFFFAOYSA-N | COC1=CC(NC2=C(C=NC3=CC(OCCCN4CCN(C)CC4)=C(OC)C=C23)C#N)=C(Cl)C=C1Cl |
34 | P12931_DB06882 | DB06882 | 1-[1-(3-aminophenyl)-3-tert-butyl-1H-pyrazol-5-yl]-3-naphthalen-1-ylurea | n/a | HJWMLCDGRWWLAQ-UHFFFAOYSA-N | CC(C)(C)C1=NN(C(NC(=O)NC2=C3C=CC=CC3=CC=C2)=C1)C1=CC=CC(N)=C1 | |
35 | P12931_DB06883 | DB06883 | 1-[1-(3-aminophenyl)-3-tert-butyl-1H-pyrazol-5-yl]-3-phenylurea | n/a | DHNYNLNKNQJSHF-UHFFFAOYSA-N | CC(C)(C)C1=NN(C(NC(=O)NC2=CC=CC=C2)=C1)C1=CC=CC(N)=C1 | |
36 | P12931_DB07335 | DB07335 | 3-[4-AMINO-1-(1-METHYLETHYL)-1H-PYRAZOLO[3,4-D]PYRIMIDIN-3-YL]PHENOL | n/a | MWYBBCLGEHZSCP-UHFFFAOYSA-N | CC(C)N1N=C(C2=C1N=CN=C2N)C1=CC=CC(O)=C1 | |
37 | P12931_DB07662 | DB07662 | PD-168393 | n/a | IC50(nM) = 27000.0 | HTUBKQUPEREOGA-UHFFFAOYSA-N | BrC1=CC(NC2=C3C=C(NC(=O)C=C)C=CC3=NC=N2)=CC=C1 |
38 | P12931_DB07966 | DB07966 | [4-({4-[(5-cyclopropyl-1H-pyrazol-3-yl)amino]quinazolin-2-yl}amino)phenyl]acetonitrile | n/a | NVMCVWOODOWOLT-UHFFFAOYSA-N | N#CCC1=CC=C(NC2=NC3=CC=CC=C3C(NC3=NNC(=C3)C3CC3)=N2)C=C1 | |
39 | P12931_DB08052 | DB08052 | PP-121 | n/a | IC50(nM) = 14.0 | NVRXTLZYXZNATH-UHFFFAOYSA-N | NC1=NC=NC2=C1C(=NN2C1CCCC1)C1=CC2=C(NC=C2)N=C1 |
40 | P12931_DB08053 | DB08053 | 1-cyclobutyl-3-(3,4-dimethoxyphenyl)-1H-pyrazolo[3,4-d]pyrimidin-4-amine | n/a | IC50(nM) = 170.0 | ITOYZJGFTNTKKR-UHFFFAOYSA-N | COC1=C(OC)C=C(C=C1)C1=NN(C2CCC2)C2=NC=NC(N)=C12 |
41 | P12931_DB08054 | DB08054 | 1-(1-methylethyl)-3-quinolin-6-yl-1H-pyrazolo[3,4-d]pyrimidin-4-amine | n/a | GEZALMMCQYDFML-UHFFFAOYSA-N | CC(C)N1N=C(C2=C(N)N=CN=C12)C1=CC2=CC=CN=C2C=C1 | |
42 | P12931_DB08192 | DB08192 | 2-(4-CARCOXY-5-ISOPROPYLTHIAZOLYL)BENZOPIPERIDINE | n/a | HCUGCUQZFBURHR-LBPRGKRZSA-N | [H][C@]1(CC2=C(CN1)C=CC=C2)C1=NC(C(O)=O)=C(S1)C(C)C | |
43 | P12931_DB08462 | DB08462 | N-(4-PHENYLAMINO-QUINAZOLIN-6-YL)-ACRYLAMIDE | n/a | IC50(nM) = 27000.0 | JGWHILNNHLDARR-UHFFFAOYSA-N | C=CC(=O)NC1=CC=C2N=CN=C(NC3=CC=CC=C3)C2=C1 |
44 | P12931_DB08564 | DB08564 | (2E)-N-{4-[(3-bromophenyl)amino]quinazolin-6-yl}-4-(dimethylamino)but-2-enamide | n/a | ZCIXBBSRVLSRJQ-QPJJXVBHSA-N | CN(C)C\C=C\C(=O)NC1=CC=C2N=CN=C(NC3=CC(Br)=CC=C3)C2=C1 | |
45 | P12931_DB08901 | DB08901 | Ponatinib | inhibitor | IC50(nM) = 2.5 | PHXJVRSECIGDHY-UHFFFAOYSA-N | CN1CCN(CC2=CC=C(NC(=O)C3=CC(C#CC4=CN=C5C=CC=NN45)=C(C)C=C3)C=C2C(F)(F)F)CC1 |
46 | P12931_DB09079 | DB09079 | Nintedanib | inhibitor | XZXHXSATPCNXJR-ZIADKAODSA-N | COC(=O)C1=CC=C2C(NC(=O)\C2=C(/NC2=CC=C(C=C2)N(C)C(=O)CN2CCN(C)CC2)C2=CC=CC=C2)=C1 | |
47 | P12931_DB12010 | DB12010 | Fostamatinib | inhibitor | GKDRMWXFWHEQQT-UHFFFAOYSA-N | COC1=CC(NC2=NC=C(F)C(NC3=NC4=C(OC(C)(C)C(=O)N4COP(O)(O)=O)C=C3)=N2)=CC(OC)=C1OC |